Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Faecal bifidobacteria and total anaerobe counts (m ± SEM, log cfu/g) in 40 healthy volunteers assigned to a 7-d consumption of short-chain fructo-oligosaccharides (scFOS) at a dose from 2.5 to 10 g/d or a placebo

From: The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans

scFOS dose (g/d)

Total anaerobes

Bifidobacteria

 

d8*

d15*

Δd15-d8

P**

d8*

d15*

Δ d15-d8

P**

0 (placebo)

12.59 ± 0.17

12.54 ± 0.12

- 0.05 ± 0.16

***

10.06 ± 0.29

9.57 ± 0.21

- 0.49 ± 0.23

***

2.5

12.32 ± 0.21

12.55 ± 0.14

+ 0.22 ± 0.19

0.29

9.15 ± 0.59

9.39 ± 0.70

+ 0.24 ± 0.16

0.02

5.0

12.48 ± 0.18

12.66 ± 0.14

+ 0.17 ± 0.28

0.51

10.21 ± 0.21

10.67 ± 0.22

+ 0.46 ± 0.31

0.03

7.5

12.45 ± 0.16

12.55 ± 0.13

+ 0.09 ± 0.06

0.42

9.28 ± 0.49

9.85 ± 0.35

+ 0.57 ± 0.25

0.01

10

11.65 ± 0.37

12.68 ± 0.14

+ 1.04 ± 0.41

0.03

9.00 ± 0.81

10.18 ± 0.60

+ 1.18 ± 0.42

0.003

  1. *days 1–8 was a run-in period during which no treatment occurred, but subjects excluded from their diet fermented dairy products containing viable bifidobacteria and limited consumption of food products containing high level of non-digestible oligosaccharides.
  2. ** Statistical analyses were performed versus placebo, on the difference d15-d8, using an unpaired t-test
  3. *** As the difference days 15-8 with placebo was the reference, p-values are not reported.